CUSIP: 337344105
Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / NASDAQ-100 SEL
-
Total 13F shares
-
9,963,723
-
Share change
-
-937,434
-
Total reported value
-
$1,249,505,272
-
Price per share
-
$125.45
-
Number of holders
-
222
-
Value change
-
-$117,179,758
-
Number of buys
-
78
-
Number of sells
-
111
Security key
337344105
Report period
Q3 2024
Institutions
222
Top holders
10
Reporting periods
Holder history for CUSIP 337344105
Recent filing periods:
Top shareholders of QQEW - FIRST TR EXCHANGE-TRADED FD - NASDAQ-100 SEL (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NASDAQ-100 SEL (QQEW) as of Q3 2024
As of 30 Sep 2024,
FIRST TR EXCHANGE-TRADED FD - NASDAQ-100 SEL (QQEW) was held by
222 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,963,723 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, RAYMOND JAMES & ASSOCIATES, LPL Financial LLC, BANK OF AMERICA CORP /DE/, UBS Group AG, Good Life Advisors, LLC, Royal Bank of Canada, ENVESTNET ASSET MANAGEMENT INC, and Atlas Private Wealth Advisors.
This page lists
222
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q3 2024 vs Q2 2024 Across Filers
| Investor |
Q2 2024 Shares |
Q3 2024 Shares |
Share Diff |
Share Chg % |
Q2 2024 Value $ |
Q3 2024 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.